Search Results - "Sayutina, E V"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Comparison of clinical-metabolic efficacy of pre- and probiotics in the conducted optimized protocols of eradication therapy of Helicobacter pylori infection by Butorova, L. I., Ardatskaya, M. D., Osadchuk, M. A., Kadnikova, N. G., Lukianova, E. I., Plavnik, R. G., Sayutina, E. V., Topchiy, T. B., Tuayeva, E. M.

    Published in Terapevtic̆eskii arhiv (19-05-2020)
    “…Low patient compliance due to the development of adverse events in the form of antibiotic-associated diarrhea (AAD) is considered as the main reason for the…”
    Get full text
    Journal Article
  2. 2

    Comparative effectiveness of ursodeoxycholic acid preparations in the treatment of biliary sludge by Butorova, L I, Ardatskaya, M D, Osadchuk, M A, Drobysheva, A E, Zagrebina, E A, Kadnikova, N G, Kalashnikova, M A, Lukianova, E I, Pavlova, L N, Plavnik, R G, Sayutina, E V, Topchiy, T B, Trunova, S N, Tuayeva, E M, Shustova, N U

    Published in Terapevtic̆eskii arhiv (03-09-2020)
    “…In the clinical classification of cholelithiasis, biliary sludge (BS) is distinguished as the pre-stone stage. Ursodeoxycholic acid (UDCA) is a drug with an…”
    Get full text
    Journal Article
  3. 3

    Fixed combinations in modern hypertension treatment algorithms by Sayutina, E. V.

    “…Modern appropriate treatment of hypertension involves the use of combination antihypertensive therapy. According to updated version of European Society of…”
    Get full text
    Journal Article
  4. 4

    Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic by Sayutina, E. V., Butorova, L. I., Tuaeva, E. M., Osadchuk, M. A., Shamuilova, M. M.

    “…Patients at high cardiovascular risk, older people with cardiovascular comorbidities, as well as those with hypertension and familial hypercholesterolemia are…”
    Get full text
    Journal Article
  5. 5

    Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits by Sayutina, E. V., Butorova, L. I., Tuaeva, E. M., Osadchuk, M. A.

    “…The current study describes pharmacological features and benefits of using the angiotensin II receptor blocker telmisartan in actual clinical practice. This…”
    Get full text
    Journal Article
  6. 6

    Statin therapy in patients with high and very high cardiovascular risk: an optimal approach by Sayutina, E. V., Shamuilova, M. M., Butorova, L. I., Tuayeva, E. M., Vertkin, A. L.

    “…This article discusses the problems of adequate therapy for dys-lipidemia in patients with high and very high cardiovascular risk in clinical practice. Updated…”
    Get full text
    Journal Article
  7. 7

    Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants? by Kryukov, N. N., Sayutina, E. V., Osadchuk, A. M., Osadchuk, M. A.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (09-02-2019)
    “…Patients with atrial fibrillation have a high risk of developing stroke and death, which requires constant anticoagulant support. In this regard, the physician…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS by A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova

    “…Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual platelet aggregative reactivity (RPAR). Material and methods…”
    Get full text
    Journal Article
  11. 11

    RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS by A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova

    “…Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual platelet aggregative reactivity (RPAR). Material and methods…”
    Get full text
    Journal Article
  12. 12

    QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION, CORONARY HEART DISEASE, AND ATHEROSCLEROTIC LESION OF LOWER EXTREMITY ARTERIES IN THE SECONDARY PREVENTION OF COMPLICATIONS by A. A. Karlov, N. A. Karlova, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva

    Published in Klinit͡s︡ist (01-07-2014)
    “…Atherosclerotic lesion of lower extremity arteries frequently complicates the long-term course of hypertension and it is generally associated with coronary…”
    Get full text
    Journal Article
  13. 13

    QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION, CORONARY HEART DISEASE, AND ATHEROSCLEROTIC LESION OF LOWER EXTREMITY ARTERIES IN THE SECONDARY PREVENTION OF COMPLICATIONS by A. A. Karlov, N. A. Karlova, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva

    Published in Klinit͡s︡ist (01-07-2014)
    “…Atherosclerotic lesion of lower extremity arteries frequently complicates the long-term course of hypertension and it is generally associated with coronary…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Control of myocardial ischemia in patients with effort angina and polyvascular atherosclerotic involvement by Saiutina, E V, Chigineva, V V, Zolozova, E A, Karlova, N A, Karlov, A A, Pshenitsin, A I, Mazur, N A

    Published in Kardiologiia (2012)
    “…In patients with ischemic heart disease with various degree of severity of atherosclerotic involvement of peripheral arteries maintenance of target levels of…”
    Get more information
    Journal Article
  17. 17